Breast cancers: acting on cells in the tumour environment to treat the cancer?
What if acting on the cells surrounding the tumour could improve the effectiveness of treatments? On 14 September 2022, a
Teclistamab: a promising new treatment for multiple myeloma
Last August, Professor Philippe Moreau, haematologist and director of SIRIC ILIAD, published a scientific article in the prestigious New England
Emotional skills: a lever to support the return to work after cancer?
What if managers’ emotional skills could help improve employees’ return to work after cancer? Marie Viseux, a doctoral student in
Physical activity, a lever for returning to work after cancer
Is physical activity a lever for a return to work after cancer? This question was the subject of a study
Immunotherapy in multiple myeloma: focus on bispecific antibodies
Last June, Professors Philippe Moreau and Cyrille Touzeau, both haematologists and researchers at SIRIC ILIAD, published a scientific article in
Cancer epidemiology – Publication of the 2016-2018 reports of the Loire-Atlantique Vendée Cancer Registry
The Loire-Atlantique Vendée Cancer Registry publishes two updated reports for each of its departments Le Registre des Cancers Loire-Atlantique Vendée,
Nantes research on astatine in the spotlight
Nantes research on astatine in the spotlight Astatine (At) is the rarest chemical element on Earth, and its 211 isotope
News : SIRIC ILIAD researchers detect the “Achilles’ heel” of a cancerous tumour
As part of the work carried out on tumour resistance, the SIRIC ILIAD teams are proud to announce the publication
